Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Sledge

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Breast Cancer Research and Treatment|May 9, 2018
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancerM L Telli, D G Stover, S Loi, et al.
Blood|May 1, 1996
A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapyM S Gordon, W J McCaskill-Stevens, L A Battiato, et al.
Oncogene|August 30, 2000
Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolideN M Patel, S Nozaki, N H Shortle, et al.
The American Journal of Gastroenterology|December 1, 1993
Colonic adenomas in asymptomatic women with a history of breast cancerD K Rex, G W Sledge, P A Harper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trialK L Tedesco, A D Thor, D H Johnson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2016
Research needs in breast cancerF Cardoso, N Harbeck, C H Barrios, et al.
ESMO Open|March 5, 2026
Genomic landscape, immune microenvironment and survival in male versus female breast cancerD Trapani, S K Deshmukh, T Samec, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical OncologyA Recht, S B Edge, L J Solin, et al.
British Journal of Cancer|August 14, 2014
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100B P Schneider, L Li, F Shen, et al.
Scientific Reports|July 2, 2025
Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumorsJ Abraham, V Domenyuk, N Perdigones, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Breast Cancer Research and Treatment|May 9, 2018
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancerM L Telli, D G Stover, S Loi, et al.
Blood|May 1, 1996
A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapyM S Gordon, W J McCaskill-Stevens, L A Battiato, et al.
Oncogene|August 30, 2000
Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolideN M Patel, S Nozaki, N H Shortle, et al.
The American Journal of Gastroenterology|December 1, 1993
Colonic adenomas in asymptomatic women with a history of breast cancerD K Rex, G W Sledge, P A Harper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trialK L Tedesco, A D Thor, D H Johnson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2016
Research needs in breast cancerF Cardoso, N Harbeck, C H Barrios, et al.
ESMO Open|March 5, 2026
Genomic landscape, immune microenvironment and survival in male versus female breast cancerD Trapani, S K Deshmukh, T Samec, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical OncologyA Recht, S B Edge, L J Solin, et al.
British Journal of Cancer|August 14, 2014
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100B P Schneider, L Li, F Shen, et al.
Scientific Reports|July 2, 2025
Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumorsJ Abraham, V Domenyuk, N Perdigones, et al.
Pageof 12